At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...

Advanced Micro Devices shows bearish near-term signals but strong growth ahead. Learn why AMD stock could be an attractive ...

Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to support critical AI-driven drug discovery tasks, including Absci's advanced de ...

Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci’s ...

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...

The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in ...

AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models.